1 |
33764527 |
10.1002/cncr.33454 |
2022 |
Screening and identification of a novel FHL2 mutation by whole exome sequencing in twins with familial Waldenström macroglobulinemia. |
IL6 |
2 |
34009095 |
10.1080/09273948.2021.1878233 |
2022 |
Consensus Recommendations for the Diagnosis of Vitreoretinal Lymphoma. |
IL6 |
3 |
34039950 |
10.1038/s41408-021-00493-5 |
2022 |
Genomic insights into the pathogenesis of Epstein-Barr virus-associated diffuse large B-cell lymphoma by whole-genome and targeted amplicon sequencing. |
IL6 |
4 |
34078642 |
10.1158/1055-9965.EPI-20-1704 |
2022 |
Cytokine Levels at Birth in Children Who Developed Acute Lymphoblastic Leukemia. |
IL6 |
5 |
34131000 |
10.1158/1078-0432.CCR-20-4167 |
2022 |
Immune Activation and Microbial Translocation as Prognostic Biomarkers for AIDS-Related Non-Hodgkin Lymphoma in the AMC-034 Study. |
IL6 |
6 |
34509934 |
10.1016/j.intimp.2021.108138 |
2022 |
LncRNA THUMPD3-AS1 enhances the proliferation and inflammatory response of chondrocytes in osteoarthritis. |
IL6 |
7 |
34542753 |
10.1007/s10517-021-05268-3 |
2022 |
Changes in Bone Marrow Stromal Progenitor Cells in Patients with Hematoblastosis at the Onset of the Disease. |
IL6 |
8 |
34691064 |
10.3389/fimmu.2021.750114 |
2022 |
Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults. |
IL6 |
9 |
34788985 |
10.3324/haematol.2021.279631 |
2022 |
Mutational landscape of high-grade B-cell lymphoma with <i>MYC-</i>, <i>BCL2</i> and/or <i>BCL6</i> rearrangements characterized by whole-exome sequencing. |
IL6 |
10 |
34935301 |
10.1002/vms3.694 |
2022 |
Neutrophilic leucocytosis induced by granulocyte colony-stimulating factor and interleukin-6 in canine primary lung adenocarcinoma. |
IL6 |
11 |
35008292 |
10.3390/cancers14010128 |
2022 |
Increased Production of B-Cell Activating Cytokines and Altered Peripheral B-Cell Subset Distribution during HIV-Related Classical Hodgkin Lymphoma. |
IL6 |
12 |
35014680 |
10.3892/mmr.2022.12592 |
2022 |
Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling. |
IL6 |
13 |
35021606 |
10.3324/haematol.2021.280003 |
2022 |
Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS. |
IL6 |
14 |
35147475 |
10.1080/10428194.2022.2038373 |
2022 |
Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma. |
IL6 |
15 |
35158867 |
10.3390/cancers14030598 |
2022 |
Diagnosing Vitreoretinal Lymphomas-An Analysis of the Sensitivity of Existing Tools. |
IL6 |
16 |
35186744 |
10.3389/fonc.2022.808511 |
2022 |
Clinical Features, Diagnosis, Management and Prognosis of Primary Intraocular Lymphoma. |
IL6 |
17 |
35187467 |
10.1016/j.clinpr.2022.100137 |
2022 |
Higher mortality of hospitalized haematologic patients with COVID-19 compared to non-haematologic is driven by thrombotic complications and development of ARDS: An age-matched cohorts study. |
IL6 |
18 |
35345499 |
10.2147/IMCRJ.S345149 |
2022 |
A Case of Intraocular Lymphoma Diagnosed by Subretinal Fluid Biopsy. |
IL6 |
19 |
35349392 |
10.1080/15384101.2022.2054096 |
2022 |
MCL-1 is a clinically targetable vulnerability in breast cancer. |
IL6 |
20 |
35399163 |
10.1155/2022/1840589 |
2022 |
Siltuximab-Related Favorable Clinical Outcome for a Patient Suffering from Idiopathic Multicentric Castleman Disease. |
IL6 |
21 |
35432366 |
10.3389/fimmu.2022.856039 |
2022 |
IL-6 and IL-10 Are Associated With Gram-Negative and Gram-Positive Bacteria Infection in Lymphoma. |
IL6 |
22 |
35546979 |
10.22092/ari.2021.356202.1803 |
2022 |
Renoprotective Potential of the Ultra-Pure Lipopolysaccharide from Rhodobacter Sphaeroides on Acutely Injured Kidneys in an Animal Model. |
IL6 |
23 |
35642002 |
10.1186/s12967-022-03451-2 |
2022 |
Role of chemokine-mediated angiogenesis in resistance towards crizotinib and its reversal by anlotinib in EML4-ALK positive NSCLC. |
IL6 |
24 |
35884913 |
10.3390/biomedicines10071608 |
2022 |
Downregulation of STAT3 in Epstein-Barr Virus-Positive Hodgkin Lymphoma. |
IL6 |
25 |
35997599 |
10.1089/vim.2021.0224 |
2022 |
Expression Pattern of Inflammatory and Anti-Inflammatory Cytokines and Key Differential Transcription Factors in Peripheral Blood Mononuclear Cells of Iranian Coronavirus Disease 2019 Patients with Different Disease Severity. |
IL6 |
26 |
36098043 |
10.1002/jcla.24689 |
2022 |
Logistic regression models of cytokines in differentiating vitreoretinal lymphoma from uveitis. |
IL6 |
27 |
30443842 |
10.1007/s12253-018-0536-z |
2021 |
The Expression of Interferon Gamma (IFN-γ) and Interleukin 6 (IL6) in Patients with Acute Lymphoblastic Leukemia (ALL). |
IL6 |
28 |
32118299 |
10.1111/bjh.16523 |
2021 |
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche. |
IL6 |
29 |
32270320 |
10.1007/s00403-020-02062-5 |
2021 |
The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility. |
IL6 |
30 |
32614271 |
10.1089/jir.2020.0012 |
2021 |
Interleukin-6-Mediated Inflammation May Cause Methotrexate-Induced Leukoencephalopathy. |
IL6 |
31 |
32669372 |
10.1158/1078-0432.CCR-20-1434 |
2021 |
Tumor Microenvironment Composition and Severe Cytokine Release Syndrome (CRS) Influence Toxicity in Patients with Large B-Cell Lymphoma Treated with Axicabtagene Ciloleucel. |
IL6 |
32 |
32767331 |
10.26355/eurrev_202008_22488 |
2021 |
Correlations of IL-6 and IL-10 gene polymorphisms with childhood acute lymphoblastic leukemia. |
IL6 |
33 |
32808859 |
10.1080/10799893.2020.1808678 |
2021 |
Regulation of cell activation by A20 through STAT signaling in acute lymphoblastic leukemia. |
IL6 |
34 |
32859946 |
10.1038/s41540-020-00145-7 |
2021 |
Mitigating the risk of cytokine release syndrome in a Phase I trial of CD20/CD3 bispecific antibody mosunetuzumab in NHL: impact of translational system modeling. |
IL6 |
35 |
32926412 |
10.1002/jmv.26516 |
2021 |
Evaluation of IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ cytokines in HIV/HHV-8 coinfection. |
IL6 |
36 |
32998963 |
10.1158/1078-0432.CCR-20-1739 |
2021 |
Itacitinib (INCB039110), a JAK1 Inhibitor, Reduces Cytokines Associated with Cytokine Release Syndrome Induced by CAR T-cell Therapy. |
IL6 |
37 |
33154497 |
10.1038/s41598-020-76206-y |
2021 |
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis. |
IL6 |
38 |
33246336 |
10.1093/humrep/deaa291 |
2021 |
N-acetylcysteine protects ovarian follicles from ischemia-reperfusion injury in xenotransplanted human ovarian tissue. |
IL6 |
39 |
33247999 |
10.1111/cas.14752 |
2021 |
Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer. |
IL6 |
40 |
33397158 |
10.1080/14737140.2021.1853531 |
2021 |
High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL). |
IL6 |
41 |
33403488 |
10.1007/s12015-020-10107-5 |
2021 |
Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient. |
IL6 |
42 |
33578562 |
10.1097/MD.0000000000024598 |
2021 |
Clinical prognosis and bioinformatic analysis of primary thyroid lymphoma. |
IL6 |
43 |
33771682 |
10.1016/j.etap.2021.103639 |
2021 |
Interleukin-6 reverses Adriamycin resistance in nasal NK/T-cell lymphoma via downregulation of ABCC4 and inactivation of the JAK2/STAT3/NF-κB/P65 pathway. |
IL6 |
44 |
33907185 |
10.1038/s41421-021-00255-4 |
2021 |
CRISPR-edited CART with GM-CSF knockout and auto secretion of IL6 and IL1 blockers in patients with hematologic malignancy. |
IL6 |
45 |
33958640 |
10.1038/s41598-021-88963-5 |
2021 |
Interplay between IL6 and CRIM1 in thiopurine intolerance due to hematological toxicity in leukemic patients with wild-type NUDT15 and TPMT. |
IL6 |
46 |
34071407 |
10.3390/cancers13112665 |
2021 |
Liquid Biopsy and Other Non-Invasive Diagnostic Measures in PCNSL. |
IL6 |
47 |
34090412 |
10.1186/s12890-021-01553-z |
2021 |
EML4-ALK-mediated activation of the JAK2-STAT pathway is critical for non-small cell lung cancer transformation. |
IL6 |
48 |
34535012 |
10.1182/bloodadvances.2021004562 |
2021 |
Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations. |
IL6 |
49 |
28018176 |
10.3389/fncel.2016.00283 |
2020 |
Activated Microglia Induce Bone Marrow Mesenchymal Stem Cells to Produce Glial Cell-Derived Neurotrophic Factor and Protect Neurons Against Oxygen-Glucose Deprivation Injury. |
IL6 |
50 |
28337303 |
|
2020 |
The involvement and possible mechanism of NR4A1 in chondrocyte apoptosis during osteoarthritis. |
IL6 |
51 |
29593668 |
10.3389/fmicb.2018.00380 |
2020 |
Simulation Study of cDNA Dataset to Investigate Possible Association of Differentially Expressed Genes of Human THP1-Monocytic Cells in Cancer Progression Affected by Bacterial Shiga Toxins. |
IL6 |
52 |
29911923 |
10.1080/10428194.2018.1461861 |
2020 |
MicroRNA-92a-3p overexpression in peripheral blood mononuclear cells is an independent predictor of prolonged overall survival of patients with chronic lymphocytic leukemia. |
IL6 |
53 |
30333224 |
10.1158/1078-0432.CCR-18-1047 |
2020 |
Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies. |
IL6 |
54 |
30368882 |
10.1002/jcb.27671 |
2020 |
MAPKs and NF-κB-mediated acrylamide-induced neuropathy in rat striatum and human neuroblastoma cells SY5Y. |
IL6 |
55 |
30668205 |
10.1080/10428194.2018.1554861 |
2020 |
Alterations in multipotent mesenchymal stromal cells from the bone marrow of acute myeloid leukemia patients at diagnosis and during treatment. |
IL6 |
56 |
30825517 |
10.1016/j.exphem.2019.02.005 |
2020 |
Difference in megakaryocyte expression of GATA-1, IL-6, and IL-8 associated with maintenance of platelet counts in patients with plasma cell neoplasm with dysmegakaryopoiesis. |
IL6 |
57 |
31355491 |
10.1111/imr.12768 |
2020 |
Cellular therapy: Immune-related complications. |
IL6 |
58 |
31417180 |
10.1038/s41388-019-0921-4 |
2020 |
T-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7. |
IL6 |
59 |
31432169 |
10.3892/mmr.2019.10565 |
2020 |
Inhibition of microRNA‑124‑3p protects against acute myocardial infarction by suppressing the apoptosis of cardiomyocytes. |
IL6 |
60 |
31515941 |
10.15252/emmm.201910576 |
2020 |
The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma. |
IL6 |
61 |
31561022 |
10.1016/j.vetimm.2019.109940 |
2020 |
Canine multicentric lymphoma exhibits systemic and intratumoral cytokine dysregulation. |
IL6 |
62 |
31568628 |
10.1111/jcmm.14653 |
2020 |
Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells. |
IL6 |
63 |
31599429 |
10.26355/eurrev_201909_19020 |
2020 |
Influence of lncRNA-MALAT1 on neuronal apoptosis in rats with cerebral infarction through regulating the ERK/MAPK signaling pathway. |
IL6 |
64 |
31601188 |
10.1186/s12885-019-6057-7 |
2020 |
Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma. |
IL6 |
65 |
31678006 |
10.1016/j.bmcl.2019.126743 |
2020 |
Discovery and optimization of a series of small-molecule allosteric inhibitors of MALT1 protease. |
IL6 |
66 |
31886296 |
10.1155/2019/2137538 |
2020 |
Impact of SNPs/Haplotypes of <i>IL10</i> and <i>IFNG</i> on the Development of Diffuse Large B-Cell Lymphoma. |
IL6 |
67 |
31894295 |
10.3892/ijmm.2019.4434 |
2020 |
MicroRNA‑15a‑5p induces pulmonary artery smooth muscle cell apoptosis in a pulmonary arterial hypertension model via the VEGF/p38/MMP‑2 signaling pathway. |
IL6 |
68 |
32034308 |
10.1038/s41388-020-1183-x |
2020 |
Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma. |
IL6 |
69 |
32124188 |
10.1007/s10552-020-01266-4 |
2020 |
Infectious mononucleosis, immune genotypes, and non-Hodgkin lymphoma (NHL): an InterLymph Consortium study. |
IL6 |
70 |
32312819 |
10.1073/pnas.1913707117 |
2020 |
Starvation and antimetabolic therapy promote cytokine release and recruitment of immune cells. |
IL6 |
71 |
32362606 |
10.4103/jcrt.JCRT_137_17 |
2020 |
Interleukin 6 and disease transformation in chronic myeloid leukemia: A Northeast Indian population study. |
IL6 |
72 |
32457601 |
10.3389/fphar.2020.00519 |
2020 |
An Integrative Pharmacology-Based Analysis of Refined Qingkailing Injection Against Cerebral Ischemic Stroke: A Novel Combination of Baicalin, Geniposide, Cholic Acid, and Hyodeoxycholic Acid. |
IL6 |
73 |
32473488 |
10.1016/j.leukres.2020.106371 |
2020 |
High serum levels of IL-2R, IL-6, and TNF-α are associated with higher tumor burden and poorer outcome of follicular lymphoma patients in the rituximab era. |
IL6 |
74 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
IL6 |
75 |
32673688 |
10.1016/j.exphem.2020.07.003 |
2020 |
Analysis of IL-6 serum levels and CAR T cell-specific digital PCR in the context of cytokine release syndrome. |
IL6 |
76 |
28674400 |
10.1038/s41598-017-04890-4 |
2019 |
Endotoxin tolerance in mast cells, its consequences for IgE-mediated signalling, and the effects of BCL3 deficiency. |
IL6 |
77 |
29496539 |
10.1016/j.canlet.2018.02.036 |
2019 |
Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer. |
IL6 |
78 |
29504848 |
10.1080/08916934.2018.1446525 |
2019 |
Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development. |
IL6 |
79 |
29866021 |
10.2174/1871520618666180604093802 |
2019 |
Curcumin Modulates Glycolytic Metabolism and Inflammatory Cytokines via Nrf 2 in Dalton's Lymphoma Ascites Cells In Vivo. |
IL6 |
80 |
29880584 |
10.1158/2159-8290.CD-17-1319 |
2019 |
Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia. |
IL6 |
81 |
30066022 |
10.1007/s00210-018-1550-0 |
2019 |
Perindopril regulates the inflammatory mediators, NF-κB/TNF-α/IL-6, and apoptosis in cisplatin-induced renal dysfunction. |
IL6 |
82 |
30097433 |
10.1158/1078-0432.CCR-18-0426 |
2019 |
A Phase I/IIa Trial Using CD19-Targeted Third-Generation CAR T Cells for Lymphoma and Leukemia. |
IL6 |
83 |
30217873 |
10.1158/0008-5472.CAN-18-0831 |
2019 |
Neonatal Inflammatory Markers Are Associated with Childhood B-cell Precursor Acute Lymphoblastic Leukemia. |
IL6 |
84 |
30458319 |
10.1016/j.leukres.2018.11.004 |
2019 |
Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology. |
IL6 |
85 |
30485406 |
10.1111/bjh.15689 |
2019 |
Antidiuretic hormone- and interleukin-6-producing angioimmunoblastic T-cell lymphoma associated with syndrome of inappropriate antidiuretic hormone secretion. |
IL6 |
86 |
30592279 |
10.3892/mmr.2018.9783 |
2019 |
Protective effect of dihydromyricetin revents fatty liver through nuclear factor‑κB/p53/B‑cell lymphoma 2‑associated X protein signaling pathways in a rat model. |
IL6 |
87 |
30628689 |
10.3892/mmr.2019.9827 |
2019 |
Low‑dose lipopolysaccharide inhibits neuronal apoptosis induced by cerebral ischemia/reperfusion injury via the PI3K/Akt/FoxO1 signaling pathway in rats. |
IL6 |
88 |
30864712 |
10.3892/mmr.2019.10014 |
2019 |
Estrogen receptor β suppresses inflammation and the progression of prostate cancer. |
IL6 |
89 |
31108175 |
10.1016/j.fsi.2019.05.034 |
2019 |
Ctenopharyngodon Idella STAT3 alleviates autophagy by up-regulating BCL-2 expression. |
IL6 |
90 |
31173173 |
10.3892/ijmm.2019.4230 |
2019 |
Hydroxysafflor Yellow A mitigated myocardial ischemia/reperfusion injury by inhibiting the activation of the JAK2/STAT1 pathway. |
IL6 |
91 |
31180523 |
10.3892/mmr.2019.10273 |
2019 |
Resveratrol alleviates inflammatory injury and enhances the apoptosis of fibroblast‑like synoviocytes via mitochondrial dysfunction and ER stress in rats with adjuvant arthritis. |
IL6 |
92 |
27098052 |
10.1039/c6lc00229c |
2018 |
In vitro micro-physiological immune-competent model of the human skin. |
IL6 |
93 |
27489357 |
10.18632/oncotarget.10966 |
2018 |
Increased frequency of circulating Th22 cells in patients with B-cell non-Hodgkin's lymphoma. |
IL6 |
94 |
27924864 |
10.1038/srep38671 |
2018 |
Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma. |
IL6 |
95 |
28061377 |
10.1016/j.bcmd.2016.12.011 |
2018 |
TNF-α increases in the CSF of children with acute lymphoblastic leukemia before CNS relapse. |
IL6 |
96 |
28092896 |
10.1182/blood-2016-02-700575 |
2018 |
Primary effusion lymphoma and concurrent progressive Kaposi sarcoma associated with elevated interleukin-6. |
IL6 |
97 |
28341757 |
10.1158/1055-9965.EPI-16-1012 |
2018 |
Elevated Serum Levels of sCD30 and IL6 and Detectable IL10 Precede Classical Hodgkin Lymphoma Diagnosis. |
IL6 |
98 |
28656237 |
10.3892/mmr.2017.6865 |
2018 |
Matrine increases the inhibitory effects of afatinib on H1975 cells via the IL‑6/JAK1/STAT3 signaling pathway. |
IL6 |
99 |
28713932 |
10.3892/mmr.2017.6927 |
2018 |
Human trypsin inhibitor reduces the apoptosis of lipopolysaccharide‑induced human kidney‑2 cells by promoting mitochondrial fusion. |
IL6 |
100 |
28791394 |
10.3892/mmr.2017.7158 |
2018 |
Identification of key genes and pathways associated with classical Hodgkin lymphoma by bioinformatics analysis. |
IL6 |